ODI Pharma AB (publ) (NGM:ODI)
Sweden flag Sweden · Delayed Price · Currency is SEK
1.710
-0.160 (-8.56%)
At close: Jul 4, 2025

ODI Pharma AB Revenue

ODI Pharma AB had revenue of 2.93M SEK in the quarter ending March 31, 2025, a decrease of -78.82%. This brings the company's revenue in the last twelve months to 10.57M, down -28.58% year-over-year. In the fiscal year ending June 30, 2024, ODI Pharma AB had annual revenue of 22.29M with 15,880.34% growth.

Revenue (ttm)
10.57M
Revenue Growth
-28.58%
P/S Ratio
2.53
Revenue / Employee
10.57M
Employees
1
Market Cap
26.74M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 202422.29M22.15M15,880.34%
Jun 30, 2023139.46K-173.48K-55.44%
Jun 30, 2022312.94K--
Jun 30, 2021---
Jun 30, 2020---
Jun 30, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Investor AB 104.49B
Atlas Copco AB 176.63B
AB Volvo 517.43B
EQT AB 30.39B
Skandinaviska Enskilda Banken AB 79.55B
ASSA ABLOY AB 152.90B
Swedbank AB 73.90B
Sandvik AB 123.18B
Revenue Rankings